The effect of white spot syndrome virus (WSSV) envelope protein VP28 on innate immunity and resistance to white spot syndrome virus in Cherax quadricarinatus

VP28 is the most abundant membrane protein of WSSV, and the recombinant protein VP28 (VP26 or VP24) was constructed for the immune protection experiment in this study. Crayfish were immunized by intramuscular injection of recombinant protein V28 (VP26 or VP24) at a dose of 2 mu g/g. The survival rate of crayfish immunized by VP28 showed a higher value than by VP26 or VP24 after WSSV challenge. Compared with the WSSV-positive control group, the VP28-immunized group could inhibit the replication of WSSV in crayfish, increasing the survival rate of crayfish to 66.67% after WSSV infection. The results of gene expression showed that VP28 treatment could enhance the expression of immune genes, mainly JAK and STAT genes. VP28 treatment also enhanced total hemocyte counts and enzyme activities including PO, SOD, and CAT in crayfish. VP28 treatment reduced the apoptosis of hemocytes in crayfish, as well as after WSSV infection. In conclusion, VP28 treatment can enhance the innate immunity of crayfish and has a significant effect on resistance to WSSV, and can be used as a preventive tool.

Automated summary

In this study, the recombinant protein VP28 (VP26 or VP24) was used for immune protection experiment. Crayfish immunized with VP28 showed a higher survival rate compared to those immunized with VP26 or VP24 after WSSV challenge. VP28 immunization inhibited WSSV replication in crayfish, increasing the survival rate to 66.67% after infection. VP28 treatment enhanced the expression of immune genes, total hemocyte counts, and enzyme activities in crayfish. It also reduced hemocyte apoptosis, both before and after WSSV infection.